Eyal C. Attar Insider Trading $APRE Aprea Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Eyal C. Attar.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Eyal C. Attar. Eyal C. Attar is SVP, Chief Medical Officer in Aprea Therapeutics, Inc. ($APRE).
Eyal C. Attar in Aprea Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Eyal C. Attar: SVP, Chief Medical Officer
Holdings: 33,000 shares
Latest Transaction: Mar 01 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Eyal C. Attar in Aprea Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Option Exercise | A | 6.00 | 143,000 | 858,000 | 143,000 | |
| Mar 01 2021 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Grant | A | 0.00 | 75,000 | 0 | 108,000 | 33 K to 108 K (+227.27 %) |
| Mar 01 2021 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Grant | A | 0.00 | 33,000 | 0 | 33,000 | 0 to 33 K |
| Mar 26 2020 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Option Exercise | A | 35.50 | 55,000 | 1,952,500 | 55,000 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Option Exercise | A | 15.00 | 77,630 | 1,164,450 | 77,630 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Option Exercise | A | 15.00 | 77,630 | 1,164,450 | 77,630 | |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
| Oct 07 2019 | APRE | Aprea Therapeutics ... | Attar Eyal C. | SVP, Chief Medical ... | Buy | P | 15.00 | 200 | 3,000 | 200 | 0 to 200 |
Page: 1